About Rephine
Rephine is a Transportation, Automotive & Logistics company based in Barcelona (Spain) founded in 2005 by Eduard Cayon and Octavi Colomina, and was acquired by RepRephinehine in July 2022. Quality supply chain services are provided for the healthcare industry. It operates on a Professional Services and Data-as-a-Service model. Its chief executive, as recorded, is Octavi Colomina. Rephine offers products and services including GMP Audit Services, GxP Consultancy, and Global Audit Library. Its focus areas include Healthcare, Pharmaceuticals, Quality Assurance Services and Medical Devices. Its legal entity is Rephineâ„¢.
Company details
Rephine is involved in delivering specialized quality assurance and GxP compliance services across the pharmaceutical, biotech, and medical device manufacturing supply chains globally. Services are extended throughout the product development lifecycle, from raw materials to patient delivery. Solutions include GMP audit services, GxP readiness assessments, digital transformation of manufacturing controls, and quality management system advisory. The company is recognized for its global audit library, offering extensive off-the-shelf reports on manufacturing sites. Tailored auditing and consultancy are provided to ensure regulatory compliance and operational efficiency in highly regulated sectors.
- Headquarters Barcelona, Spain
- Founders Eduard Cayon, Octavi Colomina
- Stage Acquired
- SectorsTransportation, Automotive & Logistics
- Phone•••• ••••
- Website forumauditorias.org
- Social LinkedIn X
- Acquired by RepRephinehine (Jul 2022)
- Legal Name Rephine™
- Investors
- Acquired byRepRephinehine
(Jul 2022)
Products & Services of Rephine
Rephine offers a comprehensive portfolio of products and services, including GMP Audit Services, GxP Consultancy, and Global Audit Library.
Auditing services for pharmaceutical supply chain compliance are provided.
Consultancy for manufacturing compliance with GxP standards is offered.
Repository of manufacturing site audit reports is maintained.
Investors in Rephine
Rephine has secured backing from 1 investor. Prominent investors backing the company include RepRephinehine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical and regulatory consulting services are provided to pharmaceutical clients. | 1998 | rephine.com | Stevenage, United Kingdom |
Investor details for Rephine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rephine
2 people are tracked at Rephine (2 in leadership).
| Name | Role | Group |
|---|---|---|
Eduard Cayon | Co-Founder & Director | Leadership |
Octavi Colomina | Co-Founder & CEO | Leadership |
Complete people profiles for Rephine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rephine
2 dated milestones of Rephine across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Rephine is founded.
- Exit Acquired by RepRephinehine.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rephine
Rephine was founded in 2005.
Rephine is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Octavi Colomina is the CEO of Rephine, as recorded in our data. They have also founded this company.
Rephine is involved in delivering specialized quality assurance and GxP compliance services across the pharmaceutical, biotech, and medical device manufacturing supply chains globally. Services are extended throughout the product development lifecycle, from raw materials to patient delivery. Solutions include GMP audit services, GxP readiness assessments, digital transformation of manufacturing controls, and quality management system advisory. The company is recognized for its global audit library, offering extensive off-the-shelf reports on manufacturing sites. Tailored auditing and consultancy are provided to ensure regulatory compliance and operational efficiency in highly regulated sectors.
Rephine offers GMP Audit Services, GxP Consultancy, and Global Audit Library.
Rephine has 1 investor. Key investors include RepRephinehine.
Rephine operates through Rephineâ„¢.
Yes. Rephine was acquired by RepRephinehine in July 2022.